Member Info for jimbobtechstock

Mm have moved from improbable spread to improbable spread so it's anyone's guess. From 1.95/.96 to 1.93/.98 And then with no trades 1.90/.95 to 1.95/2.0 AFTER the 750k then back to 1.90/.95 then down to 1.85/.90 all with no reported trades driving this. Something brewing behind the scenes and not sure whether it's seller and buyer doing a merry dance or some other issue.

They did appoint Lara Mott (see name under last couple of RNSs) for IR/PR and word is she has been tasked with promoting the opportunity to IIs etc. Problem is that institutional buyers drive a hard bargain and so it doesn't surprise me to see the spread so tight as the offer is squashed down to try and tease out more cheap shares from the seller. I think TB has a low average of 1p or thereabouts so he's in profit even at this SP which is frankly ridiculous given progress, cash in the bank and proven sales. All those research sales will be helping get the word out too.

LSE site only has one of the 2 RNSs from 17th Nov. The Aviva holdings RNS showing they have 1.45m shares out on loan is missing (link might not paste): https://www.investegate.co.uk/motif-bio-plc/rns/holding-s--in-company/201711170700057717W/ Whoever borrowed those shares and presumably sold them short to quell any chance of a rise when the major funding deal was announced presumably now has to buy them back. And the deramps about the funding deal being death spiral etc - absolutely no coincidence IMO. Nothing short of a conspiracy here to get the price down IMO. And believe me I have a dossier - dates and times of the worst manipulation - and so does the company, the company Nomad and the FCA

Crazy - Peel Hunt is on at 1.91p/1.96p if anyone's chasing the seller down they would be a good bet, with Winterflood batting for the seller?

Was NT to buy again for a while when they squeezed it under 2p and those aren't the actions of a seller. Trade at 16:09:15 was at a slight premium. Not suggesting seller has cleared - just that there's some game going on, cat-and-mouse.

Well if the holder shorts it's just forwards selling their holding and since TB seems to be struggling to find liquidity to sell into here I doubt it's him. However for other traders and MM it's a fishing expedition for them, to hook a juicy seller in at the lowest possible price. Possible shorts were opened when the market first got wind of a seller to chase the price down, first few batches of selling will be used to close the short up and the next few batches held on to ready to push the price back up and sell those on at a profit too. Just one scenario.

You might notice Laura Mott named on recent RNSs as investor relations. Word is she's a recent hire and will likely be tasked to market the company to funds and the like and drum up appetite for shares. That should help clear TB's selling. Also noting there's a decent royalty coming our way from Trevor's current company when StoneChecker gets going with sales, their CE marking expected soon too. So not sure Trevor will be selling all the way down to zero as surely he sees the direction this is all going from here. Plus the price action has been funny, that 10% rise a couple of days after final results was capped with NT to buy, as it was a few times in the intervening days. This would indicate a buyer chasing the seller down - or maybe even the MM anticipated TB's selling and have already sold some of his shares for him, without his authorisation, and now the MM need his shares to close up the shorts? Will probably clear soon enough, these things have a knack of sorting themselves out and as I say largely priced in already as his selling has been known about for 6 months.

On the plus side it has cash and pretty decent research revenue, cash burn in the FY results was modest so the runway they have to plug that loss should be considerable. (Operating loss �300,927 reduced to �266,003 after tax credit - cash at end of period �696,81. Could give runway for 12-18 months from here even allowing for increase in cost of sales, by which time uptick in revenue will hopefully stem the loss). I assume games being played over shares of departed directors but with cash in the bank, existing sales and CE marking allowing European sales to begin in addition to the Asian distributions agreements - not to mention the prospect of new spins on the product, plus the royalty revenues from StoneChecker when they start sales (CE expected soon too) - then there's good prospect of a rise out from here once the churn clears. Note the SP hardly budged after results on 7th with that opening gap sold into too, but it did bounce a bit 2 days later. By rights announcing CE mark in a few weeks, increased revenue and cash rich should have seen a better reaction on the day. AGM next week.

Thanks Tobias - a genuine Must Read of an article. Explains the bearish Wikipedia entry for iclaprim and the massively aggressive overbearing response I got from Wikipedia editors when I tried to correct inaccuracies in the article. Also my post of ADVFN on Friday tried to set the manipulation here in context of knocking the price back at various crunch points like when financing was sorted over summer and more recently the non-dilutive loan on commercial terms (met with what we know is an opening of shorts on the very day of the RNS - 15-Nov - and a corresponding block sell bear attack on AMP the same day). I believe some aspects of the manipulation here fall into the market abuse category, specifically the order-flashing seen on L2 on some days, the repeated ATs seen on once day back in winter, the failure to disclose Short Interest to the FCA and the attempt to manipulate sentiment by posting lies on stock BBs (specifically the posts about the finance being death spiral when there was no CLNs, just warrants at fair market price to give the lender access to upside when Motif is a huge success). Anyway - my post on ADVFN is still there for members to read. I've also detailed my suspicions to the company, IR and Nomad.

Almost 4:1 dilutions so yes massive kick in the balls however the pragmatist in me says that whilst it's the haircut of all haircuts it is still a chance to get some money back - vs the alternative which was administration and the only people seeing any money being liquidator's fees and maybe some premium debt holders. I think this possibly best could hope for under the circumstances assuming it can get out of suspension and float above the pitiful 0.07p SP with debt restructured

Yes RNS to confirm seller out. Transaction date stacks up too. Though leaves questions why they didn't submit a TR1 when they converted the warrants. Also the warrant conversion was 4.1% of the enlarged share cap, but as per my post below Thu 07:00 a 500k sell on the day warrants were converted would indicate a short position (forward sell). Deduct 500k from the warrant numbers and you get exactly the % share mentioned "before" in the TR1.

Looking through it appears as though the warrants executed 2 weeks ago have been flipped for �51k profit. Good news is the seller after selling over 4% of the enlarged sharecap has now cleared. Plus, there a NO MORE WARRANTS. 2,772,713 exercised @ 1.1p Exercise cost: �30,499.83p 1,672,713 on 03-Oct-17 15:49:53 @ 2.75p 600,000 on 29-Sep-17 14:47:57 @3.125p 500,000 on 18-Sep-17 13:51:52 @3.375p Returns: �81,624.61 Profit: �51,124.78 Not bad 160% profit in a couple of weeks for the warrant holder. Interesting points: 1.) There was no TR1 associated with warrant exercise despite warrants representing 4.1% of the enlarged sharecap - So possibly warrant exerciser is II subject to 5% notification limits or MM subject to 10% 2.) First dump of 500k was before the new shares had hit the market, therefore someone sold short then closed the short with the filled shares. - So again we're dealing with a pro rather than a PI. All the above IMO

Had me worried as the chart for a moment looked like lower high then lower low, but closed flat with a very long tail under the candle, which could well be bullish. Unless anyone aware of fundamentals shifting (cash might still be tight - but then again might just as well be a shift towards profitability and a drop in the SP to collect spilled shares)...

Never felt better since shutting down majority of the BBs on my LSE terminal - and then I started looking around at L2 data providers with deeper insight, so sadly once turning my back on the BBs I ended up cutting links with the whole site. But as I said will check in on BBs like this at critical junctures.

Anyhow - no offence to any regulars but I'm going back to avoiding BBs. Will hold here and maybe pop my head back in at major news on my LTHs. ATB everyone.

Great - thanks Sahid, I had skim read and where I did see a breakdown in the FYR I didn't see in the interims. All eyes on H2 now. Plus I like the way no delay getting these figures out to market. Remember conversations I relayed on to this BB before the FYR, hearing that CEO wanted to get the results out and get the past consigned to history. Both CEO and Chairman took shares with their own money - I think H2 will be the final proof the market needs to settle nerves. And that pay-down on debt will help with interest costs.

Sahid - which reports/years did you find to break down the revenue into distribution? I couldn't find 2 consecutive comparable reports with Distribution broken out but I didn't go back that far and it's really good to hear your opinion on this. My view of the March booked revenue figure is that possibly something 'happened' in February, maybe a stall/pause for a renegotiation? The words I highlighted from the receivables owed explanation coupled with the March bump made me wonder..

Thanks Fred, that March bookings figure is something I intended to mention in my post to contrast the odd bit about lower sales towards the end of the period - I'm wondering what happened in February?! Not sure about Distribution being historically weighted towards H2, there's been too many lumps and bumps over the years to get a clear picture of recurring billing filling up a specific window purely attributable to Distribution from my knowledge at least, and would be mentioned under deferred or recurring due in the next period, if it was significant?

Temporarily halting my self-imposed exile of LSE (was getting into too many ding-dongs with ridiculous position-posters maintaining flawed logic)... Overall - it's great to see profit and confirmation they turned a corner. That was all I really should have hoped for, but the very thin profit line took the shine off for me. Still very optimistic about the future - results should be seen in parallel with BOD putting their money on the line a couple of months back. A couple of notes of caution (I remain invested here so they are not affecting my position): - This odd line : "Trade and other receivables decreased by £1.0m during the period due to both improved working capital management and lower sales towards the end of the period." "lower sales towards the end of the period" - that's a bit weird, but possibly taken out of context (hopefully). - Whilst the business now has a clear identity, and is streamlined, the BOD clearly acknowledge the next challenge is to grow revenue. On the plus side, in addition to the BOD putting their own cash in, they have reduced net debt, and whilst that's cutting the cash position a bit thin it is reducing interest and looks like a shrewd calculated move to save costs going forwards. So on balance, good. I remain convinced that the trip below 8p placing price was due to a short position, that is now largely closed - no coincidence we touched 8p yesterday in advance of these numbers, what was left of the register mostly survived the 30% fall off the placing price. (Also noting the de-rampers we had on this, a largely quiet board, around the time I started to suggest I was buying into the fall at sub 7p) I'm confident the company is in profit and in the hands of someone who will look after the costs in future. The hard work still to be done - re-growing the revenue. With a very low cash buffer I think SP recovery might be slower than I had hoped and it might take a trading update with some new orders in to get it motoring. But any such update should hopefully be taken as being very positive for the company to grow out of where we are now.

Pomander, Dolphin, Sellonnews, Shylock, Greenhills, Rollthedice, the hoast of 2ats on MOD when it was 1.5p (and now it's 3p) the aholes on many other boards. Don't worry - it's just costing LSE another premium L2 member. One day they will realise the agenda posters have cost them their business model.